Pieris Pharmaceuticals

Pieris Pharmaceuticals

Biotechnology Research Boston, Massachusetts, United States 20 employees PVLA
Employees
20
Contacts
3
Emails
3
Phones
1

Pieris Pharmaceuticals Overview

Headquarters
Boston, Massachusetts, United States
Phone Number
Available in AeroLeads
Website
pieris.com
Industry
Biotechnology Research
Employees
20
Founded
2015
Stock Symbol
PVLA
Funding
5.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Pieris Pharmaceuticals

In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics, Inc. (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. For more information about the Company and updates, please visit www.palvellatx.com

Pieris Pharmaceuticals Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Pieris Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
Arne Skerra
Email
Paul Zweiacker Senior Finance Director Bei Pieris
Email
Kathleen Goode Accounting Manager @ Gourmet Caterers
Email Phone
Diana Jaquin Principle Research Associate
View

Employees by Management Level

Director 4 profiles
Senior / Lead 3 profiles
Individual contributor 3 profiles
Manager 2 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 2 2 0
Legal 1 1 0

Pieris Pharmaceuticals Tech Stack

Data / AI 5 profiles

Compare Similar Companies to Pieris Pharmaceuticals